Weiss & Lurie, a national class action and shareholder rights law firm with offices in New York City and Los Angeles, is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of American Medical Systems Holdings, Inc. (NASDAQ: AMMD) arising from its proposed acquisition by Endo Pharmaceuticals Holdings, Inc. (NASDAQ: ENDP).
Under the terms of the agreement, American Medical stockholders will receive $30 per share. Additionally, on April 10, 2011, American Medical adopted a Retention Bonus Plan, providing certain of its executive officers with a cash bonus in connection with continued employment following the merger.
Weiss & Lurie is investigating whether American Medical’s Board acted in the best interests of its shareholders in approving the transaction and whether the Board properly sought to maximize shareholder value.
If you own American Medical shares and would like more information about your rights as a shareholder or additional information concerning our investigation, please contact Michael A. Rogovin either by email at
or by telephone at (888) 593-4771.
Weiss & Lurie has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded institutions and individuals and obtained important corporate governance in these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (such as insider trading, waste of corporate assets, accounting fraud, or issuing materially misleading press releases or SEC filings), consumer fraud (such as false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at
or fill out the form on our website,
Attorney Advertising. Past results do not guarantee a similar outcome.